|
|||||
|
|
Efficacy and safety of the fixed-ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin,body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials |
|
| Authors: | Mitsuhisa Komatsu Hirotaka Watada Shizuka Kaneko Bue F Ross Agner Tomoyuki Nishida Kohei Kaku |
| Institution: | 1. Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan;2. Department of Metabolism and Endocrinology, Juntendo University, Tokyo, Japan;3. Takatsuki Red Cross Hospital, Osaka, Japan;4. Novo Nordisk A/S, Søborg, Denmark;5. Novo Nordisk Pharma Ltd., Tokyo, Japan;6. Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan |
| Abstract: | |
| Keywords: | Insulin degludec/liraglutide Japan Type 2 diabetes mellitus |